The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
New β-Lactam–β-Lactamase Inhibitor Combinations
Open accessAbstract
The limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam–β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Self-citationBoucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
van Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Wunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Motsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 372
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Tumbarello, M., Trecarichi, E. M., Corona, A., De Rosa, F. G., Bassetti, M., Mussini, C., Menichetti, F., Viscoli, C., Campoli, C., Venditti, M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy492 · Cited by 354
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., & Clancy, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02497-17 · Cited by 289
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Haidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
Li, H., Luo, Y.-F., Williams, B. J., Blackwell, T. S., & Xie, C.-M. (2012) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.10.001 · Cited by 266
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
Lucasti, C., Popescu, I., Ramesh, M. K., Lipka, J., & Sable, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks523 · Cited by 234
Hamrick, J. C., Docquier, J.-D., Uehara, T., Myers, C. L., Six, D. A., Chatwin, C. L., John, K. J., Vernacchio, S. F., Cusick, S. M., Trout, R. E. L., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01963-19 · Cited by 224
Vazquez, J. A., González Patzán, L. D., Stricklin, D., Duttaroy, D. D., Kreidly, Z., Lipka, J., & Sable, C. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.748653 · Cited by 219
Giddins, M. J., Macesic, N., Annavajhala, M. K., Stump, S., Khan, S., McConville, T. H., Mehta, M., Gomez-Simmonds, A., & Uhlemann, A.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219
Fraile-Ribot, P. A., Cabot, G., Mulet, X., Periañez, L., Martín-Pena, M. L., Juan, C., Pérez, J. L., & Oliver, A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx424 · Cited by 207
Pogue, J. M., Kaye, K. S., Veve, M. P., Patel, T. S., Gerlach, A. T., Davis, S. L., Puzniak, L. A., File, T. M., Olson, S., Dhar, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz816 · Cited by 206
Veiga, R. P., & Paiva, J.-A. (2018) · Critical Care · doi:10.1186/s13054-018-2155-1 · Cited by 203 · cited 1×
“As hydrophilic drugs, -lactams and -lactamase inhibitors have a characteristically low volume of distribution (V), akin to extracellular water, and are predominantly renally excreted (17).”
BackgroundFarrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01802-13 · Cited by 203
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
Zhang, P., Shi, Q., Hu, H., Hong, B., Wu, X., Du, X., Akova, M., & Yu, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.020 · Cited by 200
Karlowsky, J. A., Kazmierczak, K. M., de Jonge, B. L. M., Hackel, M. A., Sahm, D. F., & Bradford, P. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00472-17 · Cited by 194
Haidar, G., Clancy, C. J., Shields, R. K., Hao, B., Cheng, S., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-16 · Cited by 193
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., & Quale, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-15 · Cited by 181
Castanheira, M., Farrell, S. E., Krause, K. M., Jones, R. N., & Sader, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01896-13 · Cited by 177
Antimicrobial Resistance in Anaerobes
Rasmussen, B. A., Bush, K., & Tally, F. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s110 · Cited by 175
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
Onufrak, N. J., Forrest, A., & Gonzalez, D. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.06.015 · Cited by 170
Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 170
Nelson, K., Hemarajata, P., Sun, D., Rubio-Aparicio, D., Tsivkovski, R., Yang, S., Sebra, R., Kasarskis, A., Nguyen, H., Hanson, B. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00989-17 · Cited by 170
Gaibani, P., Campoli, C., Lewis, R. E., Volpe, S. L., Scaltriti, E., Giannella, M., Pongolini, S., Berlingeri, A., Cristini, F., Bartoletti, M., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky082 · Cited by 170
Lagacé-Wiens, P., Walkty, A., & Karlowsky, J. (2014) · Core Evidence · doi:10.2147/ce.s40698 · Cited by 169
Papp‐Wallace, K. M., Nguyen, N. Q., Jacobs, M. R., Bethel, C. R., Barnes, M. D., Kumar, V., Bajaksouzian, S., Rudin, S. D., Rather, P. N., Bhavsar, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00091 · Cited by 168
Sims, M., Mariyanovski, V., McLeroth, P., Akers, W., Lee, Y.-C., Brown, M. L., Du, J., Pedley, A., Kartsonis, N. A., & Paschke, A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx139 · Cited by 166
Sun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N., & Lomovskaya, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-17 · Cited by 166
Bassetti, M., Castaldo, N., Cattelan, A., Mussini, C., Righi, E., Tascini, C., Menichetti, F., Mastroianni, C. M., Tumbarello, M., Grossi, P., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.001 · Cited by 162
del Barrio-Tofiño, E., Zamorano, L., Cortés-Lara, S., López-Causapé, C., Sánchez-Diener, I., Cabot, G., Bou, G., Martínez-Martínez, L., Oliver, A., GEMARA-SEIMC/REIPI Pseudomonas study Group, et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz147 · Cited by 161
Papp‐Wallace, K. M. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1660772 · Cited by 156
Castón, J. J., Lacort-Peralta, I., Martín‐Dávila, P., Loeches, B., Tabares, S., Temkin, L., Torre‐Cisneros, J., & Paño‐Pardo, J. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.021 · Cited by 154
Sader, H. S., Farrell, D. J., Castanheira, M., Flamm, R. K., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku184 · Cited by 149
Sousa, A., Pérez-Rodríguez, M. T., Soto, A., Rodríguez, L., Pérez‐Landeiro, A., Martínez-Lamas, L., Nodar, A., & Casal, M. C. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky295 · Cited by 148
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Hirsch, E. B., Ledesma, K. R., Chang, K., Schwartz, M. S., Motyl, M. R., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05927-11 · Cited by 145
Self-citationWinkler, M., Papp‐Wallace, K. M., Hujer, A. M., Domitrovic, T., Hujer, K. M., Hurless, K. N., Tuohy, M. J., Hall, G. S., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04238-14 · Cited by 143
Munita, J. M., Aitken, S. L., Miller, W. R., Pérez, F., Rosa, R. M., Shimose, L. A., Lichtenberger, P. K., Abbo, L. M., Jain, R., Nigo, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix014 · Cited by 142
Haidar, G., Clancy, C. J., Chen, L., Samanta, P., Shields, R. K., Kreiswirth, B. N., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-17 · Cited by 142
Biedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
Lob, S. H., Hackel, M., Kazmierczak, K. M., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02209-16 · Cited by 140
Livermore, D. M., Mushtaq, S., Meunier, D., Hopkins, K. L., Hill, R., Adkin, R., Chaudhry, A., Pike, R., Staves, P., & Woodford, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx136 · Cited by 139
Castanheira, M., Rhomberg, P. R., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-16 · Cited by 135
Jorgensen, S. C. J., Trinh, T. D., Zasowski, E. J., Lagnf, A. M., Bhatia, S., Melvin, S. M., Steed, M. E., Simon, S. P., Estrada, S. J., Morrisette, T., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz522 · Cited by 135
Thaden, J. T., Pogue, J. M., & Kaye, K. S. (2016) · Virulence · doi:10.1080/21505594.2016.1207834 · Cited by 134
Young, K., Painter, R. E., Raghoobar, S. L., Hairston, N. N., Racine, F., Wisniewski, D., Balibar, C. J., Villafania, A., Zhang, R., Sahm, D. F., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1522-7 · Cited by 132
Sader, H. S., Castanheira, M., Duncan, L. R., & Flamm, R. K. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.04.012 · Cited by 131
Li, H., Estabrook, M. A., Jacoby, G. A., Nichols, W. W., TESTA, R. T., & Bush, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04191-14 · Cited by 130
Lahiri, S. D., Walkup, G. K., Whiteaker, J. D., Palmer, T., McCormack, K., Tanudra, M. A., Nash, T. J., Thresher, J., Johnstone, M. R., Hajec, L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv004 · Cited by 129
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Barnes, M. D., Taracila, M. A., Rutter, J. D., Bethel, C. R., Galdadas, I., Hujer, A. M., Caselli, E., Prati, F., Dekker, J. P., Papp‐Wallace, K. M., et al. (2018) · mBio · doi:10.1128/mbio.02085-18 · Cited by 129
Cornely, O. A., Cisneros, J. M., Torre‐Cisneros, J., Rodríguez-Hernández, M. J., Tallón‐Aguilar, L., Calbo, E., Horcajada, J. P., Queckenberg, C., Zettelmeyer, U., Arenz, D., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz497 · Cited by 129
Gallagher, J. C., Satlin, M. J., Elabor, A., Saraiya, N., McCreary, E. K., Molnar, E., El‐Beyrouty, C., Jones, B. M., Dixit, D., Heil, E. L., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy280 · Cited by 127
Karlowsky, J. A., Biedenbach, D. J., Kazmierczak, K. M., Stone, G. G., & Sahm, D. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02286-15 · Cited by 126
New β-lactam antibiotics and β-lactamase inhibitors
Bush, K., & Macielag, M. J. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.515588 · Cited by 120
Sader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 120
Papp‐Wallace, K. M., Bethel, C. R., Caillon, J., Barnes, M. D., Potel, G., Bajaksouzian, S., Rutter, J. D., Reghal, A., Shapiro, S., Taracila, M. A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00105-19 · Cited by 120
Morrissey, I., Magnet, S., Hawser, S., Shapiro, S., & Knechtle, P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00514-19 · Cited by 115
LUCASTI, C. J., Hershberger, E., Miller, B. W., Yankelev, S., Steenbergen, J. N., Friedland, I. R., & Solomkin, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00049-14 · Cited by 114
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 110
Yin, D., Wu, S., Yang, Y., Shi, Q., Dong, D., Zhu, D., & Hu, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02431-18 · Cited by 110
Alatoom, A. A., Elsayed, H., Lawlor, K., AbdelWareth, L., El-Lababidi, R. M., Cardona, L., Mooty, M., Bonilla, M.-F., Nusair, A. R., & Mirza, I. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.06.007 · Cited by 109
Giani, T., Arena, F., Pollini, S., Pilato, V. D., D’Andrea, M. M., Angelis, L. H. D., Bassetti, M., Rossolini, G. M., Pseudomonas aeruginosa Working Group, Vismara, C. S., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx453 · Cited by 108
VanScoy, B. D., Mendes, R. E., Nicasio, A. M., Castanheira, M., Bulik, C. C., Okusanya, Ó. O., Bhavnani, S. M., Forrest, A., Jones, R. N., Friedrich, L. V., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02513-12 · Cited by 107
Zhang, Y., Kashikar, A., Brown, C. A., Denys, G. A., & Bush, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-17 · Cited by 107
Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 107
Shields, R. K., McCreary, E. K., Marini, R. V., Kline, E. G., Jones, C. E., Hao, B., Chen, L., Kreiswirth, B. N., Doi, Y., Clancy, C. J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1131 · Cited by 106
Compain, F., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-17 · Cited by 101
Pfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Onorato, L., Caprio, G. D., Signoriello, S., & Coppola, N. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.025 · Cited by 97
Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96
Buehrle, D. J., Shields, R. K., Chen, L., Hao, B., Press, E. G., Alkrouk, A., Potoski, B. A., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02969-15 · Cited by 95
Galani, I., Karaiskos, I., Karantani, I., Papoutsaki, V., Maraki, S., Papaioannou, V., Kazila, P., Tsorlini, H., Charalampaki, N., Toutouza, M. G., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.30.1700775 · Cited by 93
Karaiskos, I., Galani, I., Souli, M., & Giamarellou, H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1563071 · Cited by 92
McLeod, S. M., Moussa, S. H., Hackel, M., & Miller, A. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-19 · Cited by 92
Kazmierczak, K. M., Bradford, P. A., Stone, G. G., DeJonge, B. L. M., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-18 · Cited by 91
Tsolaki, V., Mantzarlis, K. D., Mpakalis, A., Malli, E., Tsimpoukas, F., Tsirogianni, A., Papagiannitsis, C., Zygoulis, P., Papadonta, M.-E., Petinaki, E., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02320-19 · Cited by 91
Livermore, D. M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt118 · Cited by 90
Athans, V., Neuner, E. A., Hassouna, H., Richter, S. S., Keller, G., Castanheira, M., Brizendine, K. D., & Mathers, A. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01551-18 · Cited by 90
Molecular Basis of Class A β-Lactamase Inhibition by Relebactam
Tooke, C. L., Hinchliffe, P., Lang, P. A., Mulholland, A. J., Brem, J., Schofield, C. J., & SPENCER, J. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00564-19 · Cited by 89
Gaibani, P., Re, M. C., Campoli, C., Viale, P., & Ambretti, S. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.011 · Cited by 89
Sader, H. S., Mendes, R. E., Pfaller, M. A., Shortridge, D., Flamm, R. K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01856-17 · Cited by 87
Fraile-Ribot, P. A., Zamorano, L., Orellana, R., del Barrio-Tofiño, E., Sánchez-Diener, I., Cortés-Lara, S., López-Causapé, C., Cabot, G., Bou, G., Martı́nez-Martı́nez, L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-19 · Cited by 87
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Hawser, S., Magnet, S., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky107 · Cited by 86
Sader, H. S., Castanheira, M., Mendes, R. E., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky279 · Cited by 86
Wilson, W. R., Kline, E. G., Jones, C. E., Morder, K. M., Mettus, R. T., Doi, Y., Nguyen, M. H., Clancy, C. J., & Shields, R. K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02048-18 · Cited by 85
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms
Tamma, P. D., & Hsu, A. J. (2019) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piz002 · Cited by 85
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
la Calle, C. D., Rodríguez-Núñez, O., Morata, L., Marco, F., Cardozo, C., García‐Vidal, C., del Río, A., Fehér, C., Pellicé, M., Puerta‐Alcalde, P., et al. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.015 · Cited by 83
Yasmin, M., Fouts, D. E., Jacobs, M. R., Haydar, H., Marshall, S. H., White, R. C., D’Souza, R., Lodise, T. P., Rhoads, D. D., Hujer, A. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1155 · Cited by 83
Alraddadi, B. M., Saeedi, M. F., Qutub, M., Alshukairi, A. N., Hassanien, A., & Wali, G. Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4409-1 · Cited by 82
Mojica, M. F., Papp‐Wallace, K. M., Taracila, M. A., Barnes, M. D., Rutter, J. D., Jacobs, M. R., LiPuma, J. J., Walsh, T. J., Vila, A. J., & Bonomo, R. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00777-17 · Cited by 81
Mojica, M. F., Ouellette, C. P., Leber, A. L., Becknell, B., Ardura, M. I., Pérez, F., Shimamura, M., Bonomo, R. A., Aitken, S. L., & Shelburne, S. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-16 · Cited by 80
Spiliopoulou, I. T., Kazmierczak, K. M., & Stone, G. G. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz456 · Cited by 80
Sader, H. S., Castanheira, M., Huband, M. D., Jones, R. N., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-17 · Cited by 79
Papp‐Wallace, K. M., Becka, S. A., Zeiser, E. T., Ohuchi, N., Mojica, M. F., Gatta, J. A., Falleni, M., Tosi, D., Borghi, E., Winkler, M., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00020 · Cited by 79
Senchyna, F., Gaur, R. L., Sandlund, J., Truong, C., Tremintin, G., Kültz, D., Gómez, C. A., Tamburini, F. B., Andermann, T. M., Bhatt, A. S., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.004 · Cited by 78
Karlowsky, J. A., Kazmierczak, K. M., Bouchillon, S. K., DeJonge, B. L. M., Stone, G. G., & Sahm, D. F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01814-18 · Cited by 77
Stone, G. G., Newell, P., Gasink, L. B., Broadhurst, H., Wardman, A., Yates, K., Chen, Z., Song, J., & Chow, J. W. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky204 · Cited by 77
Bradley, J. S., Broadhurst, H., Cheng, K., Hernández, M. J. M., Newell, P., Prchlík, M., Stone, G. G., Talley, A. K., Tawadrous, M., Wajsbrot, D., et al. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002392 · Cited by 77
Cañestro, M. D., Periañez, L., Mulet, X., Martín-Pena, M. L., Fraile-Ribot, P. A., Ayestarán, I., Colomar, A., Núñez, B., Macia, M. D., Novo, A., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3361-0 · Cited by 76
Tam, V. H., Louie, A., Lomaestro, B. M., & Drusano, G. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.3.291.32110 · Cited by 74
Self-citationKaushik, A., Ammerman, N. C., Lee, J., Martins, O., Kreiswirth, B. N., Lamichhane, G., Parrish, N. M., & Nuermberger, E. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02623-18 · Cited by 74
New promising β-lactamase inhibitors for clinical use
Olsen, I. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2375-0 · Cited by 73
Zhou, H., Zhang, K., Chen, W., Chen, J., Zheng, J., Liu, C., Li, C., Zhou, W., Shen, H., & Cao, X. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0674-4 · Cited by 71
Periasamy, H., Joshi, P., Palwe, S. R., Shrivastava, R., Bhagwat, S., & Patel, M. V. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa021 · Cited by 71
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Efficacy and safety of ceftazidime/avibactam: a systematic review and meta-analysis
Sternbach, N., Weissman, Y. L., Avni, T., & Yahav, D. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky124 · Cited by 69
Self-citationAitken, S. L., Tarrand, J. J., Deshpande, L. M., Tverdek, F. P., Jones, A. L., Shelburne, S. A., Prince, R. A., Bhatti, M. M., Rolston, K. V. I., Jones, R. N., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw398 · Cited by 68
Sader, H. S., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02083-16 · Cited by 68
Tato, M., García-Castillo, M., Bofarull, A. M., & Cantón, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.004 · Cited by 63
Sy, S. K. B., Zhuang, L., Sy, S., & Derendorf, H. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0705-y · Cited by 62
Sader, H. S., Flamm, R. K., Carvalhaes, C. G., & Castanheira, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01587-18 · Cited by 62
Barnes, M. D., Taracila, M. A., Good, C. E., Bajaksouzian, S., Rojas, L. J., van Duin, D., Kreiswirth, B. N., Jacobs, M. R., Haldimann, A., Papp‐Wallace, K. M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00432-19 · Cited by 62
Castanheira, M., Duncan, L. R., Mendes, R. E., Sader, H. S., & Shortridge, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02125-17 · Cited by 61
Wu, J., Racine, F., Wismer, M. K., Young, K., Carr, D. M., Xiao, J. C., Katwaru, R., Si, Q., Harradine, P. J., Motyl, M. R., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02323-17 · Cited by 61
Sagan, O., Yakubsevitch, R., Yanev, K. P., Fomkin, R. N., Stone, E., Hines, D. J., O’Donnell, J. P., Miller, A. A., Isaacs, R., & Srinivasan, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01506-19 · Cited by 61
Sutherland, C. A., & Nicolau, D. P. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.501 · Cited by 60
Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors
Bhagunde, P. R., Chang, K., Hirsch, E. B., Ledesma, K. R., Nikolaou, M., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06113-11 · Cited by 60
Self-citationHuntington, J. A., Sakoulas, G., Umeh, O., Cloutier, D. J., Steenbergen, J. N., Bliss, C. A., & Goldstein, E. J. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw053 · Cited by 60
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
Escolà‐Vergé, L., Pigrau, C., Arcos, I. L., Arévalo, Á., Viñado, B., Campany, D., Larrosa, N., Nuvials, X., Ferrer, R., Len, Ó., et al. (2018) · Infection · doi:10.1007/s15010-018-1133-5 · Cited by 60
Jorgensen, S. C. J., Trinh, T. D., Zasowski, E. J., Lagnf, A. M., Simon, S. P., Bhatia, S., Melvin, S. M., Steed, M. E., Finch, N. A., Morrisette, T., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02291-19 · Cited by 60
Iosifidis, Ε., Chorafa, E., Agakidou, E., Kontou, A., Violaki, A., Volakli, E., Christou, E.-I., Zarras, C., Drossou-Agakidou, V., Σδούγκα, Μ., et al. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002344 · Cited by 59
Karlowsky, J. A., Lob, S. H., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.07.012 · Cited by 57
Zhong, H., Zhao, X., Zhang, Z.-L., Gu, Z., Zhang, C., Gao, Y., & Cui, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.07.004 · Cited by 57
Castanheira, M., Mendes, R. E., & Sader, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02369-16 · Cited by 55
Rodríguez-Núñez, O., Ripa, M., Morata, L., de la Calle, C., Cardozo, C., Fehér, C., Pellicé, M., Valcárcel, A., Puerta‐Alcalde, P., Marco, F., et al. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.07.010 · Cited by 55
Tselepis, L., Langley, G. W., Aboklaish, A. F., Widlake, E., Jackson, D. E., Walsh, T. R., Schofield, C. J., Brem, J., & Tyrrell, J. M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105925 · Cited by 54
Lob, S. H., Hackel, M., Kazmierczak, K. M., Hoban, D. J., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.02.018 · Cited by 53
Shortridge, D., Pfaller, M. A., Castanheira, M., & Flamm, R. K. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0266 · Cited by 53
Sader, H. S., Flamm, R. K., Carvalhaes, C. G., & Castanheira, M. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.005 · Cited by 53
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Young, K., Motyl, M. R., & Sahm, D. F. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.10.028 · Cited by 52
Phe, K., Heil, E. L., & Tam, V. H. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa118 · Cited by 52
Self-citationZamudio, R., Hijazi, K., Joshi, C., Aitken, E., Oggioni, M. R., & Gould, I. M. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.022 · Cited by 51
Pfaller, M. A., Shortridge, D., Sader, H. S., Gales, A. C., Castanheira, M., & Flamm, R. K. (2017) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.06.008 · Cited by 50
Lomovskaya, O., Nelson, K. J., Rubio-Aparicio, D., Tsivkovski, R., Sun, D., & Dudley, M. N. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00552-20 · Cited by 49
Carvalhaes, C. G., Castanheira, M., Sader, H. S., Flamm, R. K., & Shortridge, D. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.11.021 · Cited by 48
Dinh, A., Wyplosz, B., Kernéis, S., Lebeaux, D., Bouchand, F., Duran, C., Béraud, G., Lazaro, P., Davido, B., Hénard, S., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.001 · Cited by 47
Collaborators, O. B. O. T. S., Galani, I., Souli, M., Nafplioti, K., Adamou, P., Karaiskos, I., Giamarellou, H., & Antoniadou, A. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03517-y · Cited by 47
Tamma, P. D., Fan, Y., Bergman, Y., Sick-Samuels, A. C., Hsu, A. J., Timp, W., Simner, P. J., Prokesch, B. C., & Greenberg, D. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02213-17 · Cited by 46
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-18 · Cited by 46
Ekkelenkamp, M. B., Cantón, R., Diez‐Aguilar, M., Tunney, M. M., Gilpin, D. F., Bernardini, F., Dale, G. E., Elborn, J. S., Bayjanov, J. R., & Fluit, A. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01541-19 · Cited by 46
Pfaller, M. A., Shortridge, D., Sader, H. S., Castanheira, M., & Flamm, R. K. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.09.016 · Cited by 44
The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent
Deshpande, D., Srivastava, S., Chapagain, M. L., Lee, P. S., Cirrincione, K. N., Pasipanodya, J. G., & Gumbo, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx306 · Cited by 44
Sun, L., Chen, W., Li, H., Li, L., Zou, X., Zhao, J., Lu, B., Li, B., Wang, C., Li, H., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa241 · Cited by 44
Schmidt-Malan, S. M., Mishra, A. J., Mushtaq, A., Brinkman, C. L., & Patel, R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00533-18 · Cited by 43
Larson, K. B., Patel, Y. T., Willavize, S. A., Bradley, J. S., Rhee, E. G., Caro, L., & Rizk, M. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02578-18 · Cited by 43
Xipell, M., Paredes, S., Fresco, L., Bodro, M., Marco, F., Martínez, J. A., & Soriano, À. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.01.010 · Cited by 40
Shortridge, D., Pfaller, M. A., Castanheira, M., & Flamm, R. K. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.05.011 · Cited by 40
Caverly, L. J., Spilker, T., Kalikin, L. M., Stillwell, T. L., Young, C. L., Huang, D. B., & LiPuma, J. J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01595-19 · Cited by 40
Asempa, T. E., Motos, A., Abdelraouf, K., Bissantz, C., Zampaloni, C., & Nicolau, D. P. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.10.019 · Cited by 40
Vena, A., Giacobbe, D. R., Mussini, C., Cattelan, A. M., Bassetti, M., Ceftabuse Study Group, Bassetti, M., Vena, A., Castaldo, N., Pecori, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa003 · Cited by 40
Ahmed, M. A. S., Hadi, H. A., Hassan, A. A. I., Jarir, S. H. A., Almaslamani, M., Eltai, N. O., Dousa, K. M., Hujer, A. M., Sultan, A. A., Söderquist, B., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz379 · Cited by 38
Walkty, A. J., Karlowsky, J. A., Adam, H. J., Baxter, M. R., Lagacé-Wiens, P. R. S., Hoban, D. J., & Zhanel, G. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01404-13 · Cited by 37
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Young, K., Motyl, M. R., & Sahm, D. F. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.10.022 · Cited by 35
Sader, H. S., Castanheira, M., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.008 · Cited by 34
Carpenter, J., Neidig, N., Campbell, A., Thornsberry, T., Truex, T., Fortney, T., Zhang, Y., & Bush, K. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz354 · Cited by 34
Carvalhaes, C. G., Shortridge, D., Sader, H. S., & Castanheira, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02177-19 · Cited by 34
Spoletini, G., Etherington, C., Shaw, N., Clifton, I., Denton, M., Whitaker, P., & Peckham, D. G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky558 · Cited by 33
Castanheira, M., Arends, S. J. R., Davis, A. P., Woosley, L. N., Bhalodi, A. A., & MacVane, S. H. (2018) · mSphere · doi:10.1128/msphere.00408-18 · Cited by 32
Arakawa, S., Kawahara, K., Kawahara, M., Yasuda, M., Fujimoto, G., Sato, A., Yokokawa, R., Yoshinari, T., Rhee, E. G., & Aoyama, N. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.10.009 · Cited by 31
Schaumburg, F., Bletz, S., Mellmann, A., Becker, K., & Idelevich, E. A. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.05.001 · Cited by 31
Sader, H. S., Castanheira, M., Streit, J. M., & Flamm, R. K. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.06.002 · Cited by 31
Sader, H. S., Castanheira, M., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-16 · Cited by 30
New pharmacological opportunities for the treatment of invasive mould diseases
Ledoux, M., Toussaint, E., Denis, J., & Herbrecht, R. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx033 · Cited by 30
Atkin, S. D., Abid, S., Foster, M., Bose, M., Keller, A. E., Hollaway, R., Sader, H. S., Greenberg, D. E., Finklea, J. D., Castanheira, M., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173804 · Cited by 30
So, W., Shurko, J. F., Galega, R., Quilitz, R. E., Greene, J. N., & Lee, G. C. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky393 · Cited by 30
Kohno, S., Bando, H., Yoneyama, F., Kikukawa, H., Kawahara, K., Shirakawa, M., Aoyama, N., Brown, M. L., Paschke, A. A., & Takase, A. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.09.032 · Cited by 30
Daccò, V., Claut, L., Piconi, S., Castellazzi, L., Garbarino, F., Teri, A., & Colombo, C. (2019) · Transplant Infectious Disease · doi:10.1111/tid.13082 · Cited by 28
Massip, C., Mathieu, C., Gaudru, C., Miaut, V., Floch, P., Oswald, É., Segonds, C., & Guet‐Revillet, H. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky423 · Cited by 27
Hanretty, A. M., Kaur, I., Evangelista, A. T., Moore, W. S., Enache, A., Chopra, A., & Cies, J. J. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2187 · Cited by 27
Walkty, A. J., Adam, H. J., Baxter, M. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx468 · Cited by 25
Abodakpi, H., Wanger, A. R., & Tam, V. H. (2019) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2019.05.006 · Cited by 25
Self-citation
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1013 · Cited by 519
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Ding, L., Shen, S., Chen, J., Tian, Z., Shi, Q., Han, R., Guo, Y., & Hu, F. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-23 · Cited by 222
“A study by Papp-Wallace et al. showed that all Enterobac terales strains were highly susceptible to imipenem-relebactam (MIC ≤2 mg/L) (113).”
MethodSource control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines
Coccolini, F., Sartelli, M., Sawyer, R., Rasa, K., Viaggi, B., Abu-Zidan, F., Soreide, K., Hardcastle, T., Gupta, D., Bendinelli, C., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00509-4 · Cited by 99
Metadata
- Authors
- Yahav, D., Giske, C. G., Grāmatniece, A., Abodakpi, H., Tam, V. H., & Leibovici, L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-12-16
- Volume
- 34
- Issue
- 1
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3106009346
- Cited by
- 521
- References
- 221
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.